Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 51-75 of 798 matching filings.

Per page
25
Current page
3
4

FORM 4

Filing date
29 Dec 2025
Reporting date
29 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-88806

SC 14D9/A

Filing date
19 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-88806

SC TO-T/A

Filing date
19 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-88806

SC TO-T/A

Filing date
17 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-88806

SC 14D9

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88806

SCHEDULE 13D/A filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-88806

SC14D9C

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-88806

SC TO-C

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88806

SCHEDULE 13D/A filing

Filing date
10 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
06 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
06 Nov 2025
Reporting date
06 Nov 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
17 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
17 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .